Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
Cupric Sulfate is an injectable mineral supplement containing copper, an essential trace element required for numerous enzymatic and physiologic processes. It is used primarily in parenteral nutrition formulations to prevent copper deficiency in patients unable to obtain adequate copper through oral intake. The drug works by providing bioavailable copper ions that integrate into metalloenzymes critical for iron metabolism, connective tissue synthesis, and neurological function.
As a mature, off-patent injectable mineral supplement with limited growth prospects, this product likely operates with a small, lean commercial team focused on cost management rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Cupric Sulfate offers limited career advancement potential given its mature, off-patent status and absence of linked commercial roles. Career value lies primarily in operational excellence, regulatory maintenance, and supply chain optimization rather than revenue growth or market expansion.
Worked on CUPRIC SULFATE at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.